The new studies could pave the way for anti-cancer therapies that control the makeup of these bacterial communities.

The technique accurately predicted relapse in 12 of 15 patients about eight months before their tumors were spotted by conventional imaging.

A new study using mouse tumors and human lung cancer cells helps explain why taking antioxidants could accelerate the growth of early tumors or precancerous lesions in high-risk populations.

Two mouse studies published this week suggest innovative approaches for treating two of the developed world’s most troubling diseases. One study tests a potential therapy using an FDA-approved cancer drug to treat Alzheimer’s, while the other examines how a few days of fasting may delay tumor growth and improve chemotherapy.